Current evidence on efficacy of COVID-19 booster dose vaccination against the Omicron variant: A systematic review

被引:222
作者
Chenchula, Santenna [1 ]
Karunakaran, Padmavathi [2 ]
Sharma, Sushil [1 ]
Chavan, Madhavrao [1 ]
机构
[1] All India Inst Med Sci AIIMS, Dept Pharmacol, 3rd FI, Mangalagiri 522503, Andhra Pradesh, India
[2] SVS Med Coll & Hosp, Med, Mahabubbnagar, Telangana, India
关键词
booster dose; COVID-19; vaccine; Omicron; SARS CoV-2;
D O I
10.1002/jmv.27697
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Coronavirus disease 2019 (COVID-19) is an ongoing pandemic, which affected around 27 million confirmed cases of COVID-19, including more than 5 million deaths. However, on November 24, 2021, the World Health Organization announced a new severe acute respiratory syndrome coronavirus 2 variant designated as the B.1.1.529, a variant of concern (VOC), and the variant has been named as "Omicron." Available preliminary evidence suggests that, as compared with previous VOCs, it has an increased risk of infectivity. Studies have shown that protection from various vaccines effectiveness against hospitalization and death from severe COVID-19 disease is decreasing slowly after a two-dose schedule of COVID-19 vaccines. In response to experiencing a new COVID-19 variant and ongoing resurgence of cases, the importance of COVID-19 vaccine booster dose and durability of the effect of the third dose of vaccine against COVID-19 Omicron variant is controversial yet. To address this, we conducted a systematic literature survey on effectiveness of the third or booster dose of COVID-19 vaccine against the Omicron variant. We have performed a systematic search in PubMed (Medline), Google Scholar, and MedRXiv database, from inception to January 2022 using the MeSH terms and keywords "Corona Virus Disease-2019 OR COVID-19 AND Omicron AND COVID-19 Booster Vaccine." We have identified a total of 27 published studies. We have reviewed all the eligible available studies on the effectiveness of the COVID-19 vaccine booster shots against the Omicron variant. This review may be helpful in accelerating the COVID-19 booster dose vaccination.
引用
收藏
页码:2969 / 2976
页数:8
相关论文
共 37 条
[1]   Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants [J].
Accorsi, Emma K. ;
Britton, Amadea ;
Fleming-Dutra, Katherine E. ;
Smith, Zachary R. ;
Shang, Nong ;
Derado, Gordana ;
Miller, Joseph ;
Schrag, Stephanie J. ;
Verani, Jennifer R. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 327 (07) :639-651
[2]  
Andrews N, BIORXIV, V2021, DOI [10.1101/2021.11.15.21266341, DOI 10.1101/2021.11.15.21266341]
[3]   Duration of Protection against Mild and Severe Disease by Covid-19 Vaccines [J].
Andrews, Nick ;
Tessier, Elise ;
Stowe, Julia ;
Gower, Charlotte ;
Kirsebom, Freja ;
Simmons, Ruth ;
Gallagher, Eileen ;
Thelwall, Simon ;
Groves, Natalie ;
Dabrera, Gavin ;
Myers, Richard ;
Campbell, Colin N. J. ;
Amirthalingam, Gayatri ;
Edmunds, Matt ;
Zambon, Maria ;
Brown, Kevin ;
Hopkins, Susan ;
Chand, Meera ;
Ladhani, Shamez N. ;
Ramsay, Mary ;
Bernal, Jamie Lopez .
NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (04) :340-350
[4]  
[Anonymous], 2021, Implications of the further emergence and spread of the SARS-CoV-2 B.1.1.529 variant of concern (Omicron) for the EU/EEA-first update
[5]  
[Anonymous], 2021, Guidance for representative and targeted genomic SARS-COV-2 monitoring Internet
[6]   Homologous and Heterologous Covid-19 Booster Vaccinations [J].
Atmar, R. L. ;
Lyke, K. E. ;
Deming, M. E. ;
Jackson, L. A. ;
Branche, A. R. ;
El Sahly, H. M. ;
Rostad, C. A. ;
Martin, J. M. ;
Johnston, C. ;
Rupp, R. E. ;
Mulligan, M. J. ;
Brady, R. C. ;
Frenck, R. W., Jr. ;
Backer, M. ;
Kottkamp, A. C. ;
Babu, T. M. ;
Rajakumar, K. ;
Edupuganti, S. ;
Dobrzynski, D. ;
Coler, R. N. ;
Posavad, C. M. ;
Archer, J., I ;
Crandon, S. ;
Nayak, S. U. ;
Szydlo, D. ;
Zemanek, J. A. ;
Islas, C. P. Dominguez ;
Brown, E. R. ;
Suthar, M. S. ;
McElrath, M. J. ;
McDermott, A. B. ;
Montefiori, D. C. ;
Eaton, A. ;
Neuzil, K. M. ;
Stephens, D. S. ;
Roberts, P. C. ;
Beigel, J. H. .
NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (11) :1046-1057
[7]   Protection of BNT162b2 Vaccine Booster against Covid-19 in Israel [J].
Bar-On, Yinon M. ;
Goldberg, Yair ;
Mandel, Micha ;
Bodenheimer, Omri ;
Freedman, Laurence ;
Kalkstein, Nir ;
Mizrahi, Barak ;
Alroy-Preis, Sharon ;
Ash, Nachman ;
Milo, Ron ;
Huppert, Amit .
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (15) :1393-1400
[8]   Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study [J].
Barda, Noam ;
Dagan, Noa ;
Cohen, Cyrille ;
Hernan, Miguel A. ;
Lipsitch, Marc ;
Kohane, Isaac S. ;
Reis, Ben Y. ;
Balicer, Ran D. .
LANCET, 2021, 398 (10316) :2093-2100
[9]   Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study [J].
Costa Clemens, Sue Ann ;
Weckx, Lily ;
Clemens, Ralf ;
Almeida Mendes, Ana Verena ;
Souza, Alessandra Ramos ;
Silveira, Mariana B., V ;
Farias da Guarda, Suzete Nascimento ;
de Nobrega, Maristela Miyamoto ;
de Moraes Pinto, Maria Isabel ;
Gonzalez, Isabela G. S. ;
Salvador, Natalia ;
Franco, Marilia Miranda ;
de Avila Mendonca, Renata Navis ;
Queiroz Oliveira, Isabelle Silva ;
de Freitas Souza, Bruno Solano ;
Fraga, Mayara ;
Aley, Parvinder ;
Bibi, Sagida ;
Cantrell, Liberty ;
Dejnirattisai, Wanwisa ;
Liu, Xinxue ;
Mongkolsapaya, Juthathip ;
Supasa, Piyada ;
Screaton, Gavin R. ;
Lambe, Teresa ;
Voysey, Merryn ;
Pollard, Andrew J. .
LANCET, 2022, 399 (10324) :521-529
[10]  
Discovery Health, S AFRICAS LARGEST PR